Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3′,5′-cyclic adenosine 5′-monophosphate response element-binding protein and the generation of reactive oxygen species

Endocrinology

Volumn 149, Issue 7, 2008, Pages 3635-3642

  Fürst, Robert ^a   Zahler, Stefan ^a   Vollmar, Angelika M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIC AMP; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ANTHRACENES; BLOTTING, WESTERN; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEXAMETHASONE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TIME FACTORS; TRANSCRIPTION FACTOR AP-1;

EID: 46349089092     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1524     Document Type: Article

References (34)

1. Schaaf MJ, Cidlowski JA 2002 Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83:37-48
2. Clark AR, Lasa M 2003 Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 3:404-411
3. Clark AR 2007 Anti-inflammatory functions of glucocorticoid- induced genes. Mol Cell Endocrinol 275:79-97
4. Fürst R, Schroeder T, Eilken HM, Bubik MF, Kiemer AK, Zahler S, Vollmar AM 2007 MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J 21:74-80
5. Lang R, Hammer M, Mages J 2006 DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 177:7497-7504
6. Abraham SM, Clark AR 2006 Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem Soc Trans 34:1018-1023
7. Dickinson RJ, Keyse SM 2006 Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119:4607-4615
8. Liu Y, Shepherd EG, Nelin LD 2007 MAPK phosphatases: regulating the immune response. Nat Rev Immunol 7:202-212
9. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR 2006 Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203:1883-1889
10. Kiemer AK, Weber NC, Fürst R, Bildner N, Kulhanek-Heinze S, Vollmar AM 2002 Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-α-induced actin polymerization and endothelial permeability. Circ Res 90:874-881
11. Kiemer AK, Weber NC, Vollmar AM 2002 Induction of IκB: atrial natriuretic peptide as a regulator of the NF-κB pathway. Biochem Biophys Res Commun 295:1068-1076
12. Fürst R, Brueckl C, Kuebler WM, Zahler S, Krötz F, Görlach A, Vollmar AM, Kiemer AK 2005 Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96:43-53
13. Hafezi-Moghadam A, Simoncini T, Yang E, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK 2002 Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473-479
14. Limbourg FP, Huang Z, Plumier JC, Simoncini T, Fujioka M, Tuckermann J, Schutz G, Moskowitz MA, Liao JK 2002 Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110:1729-1738
15. Sanchez-Tillo E, Comalada M, Xaus J, Farrera C, Valledor AF, Caelles C, Lloberas J, Celada A 2007 JNK1 Is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation. J Biol Chem 282:12566-12573
16. Bokemeyer D, Sorokin A, Yan M, Ahn NG, Templeton DJ, Dunn MJ 1996 Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J Biol Chem 271:639-642
17. Bokemeyer D, Lindemann M, Kramer HJ 1998 Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells. Hypertension 32:661-667
18. Kim F, Corson MA 2000 Adhesion to fibronectin enhances MKP-1 activation in human endothelial cells. Biochem Biophys Res Commun 273:539-545
19. Pelaia G, Cuda G, Vatrella A, Grembiale RD, De Sarro G, Maselli R, Costanzo FS, Avvedimento VE, Rotiroti D, Marsico SA 2001 Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem Pharmacol 62:1719-1724
20. Sun H, Charles CH, Lau LF, Tonks NK 1993 MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493
21. Kwak SP, Hakes DJ, Martell KJ, Dixon JE 1994 Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J Biol Chem 269:3596-3604
22. Castro-Caldas M, Mendes AF, Duarte CB, Lopes MC 2003 Dexamethasone-induced and estradiol-induced CREB activation and annexin 1 expression in CCRF-CEM lymphoblastic cells: evidence for the involvement of cAMP and p38 MAPK. Mediators Inflamm 12:329-337
23. Fürst R, Blumenthal SB, Kiemer AK, Zahler S, Vollmar AM 2006 Nuclear factor-κB-independent anti-inflammatory action of salicylate in human endothelial cells: induction of heme oxygenase-1 by the c-jun N-terminal kinase/activator protein-1 pathway. J Pharmacol Exp Ther 318:389-394
24. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T 2003 Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81-87
25. Zahler S, Kupatt C, Becker BF 2000 Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-α. FASEB J 14:555-564
26. Stahn C, Lowenberg M, Hommes DW, Buttgereit F 2007 Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275:71-78
27. Qiu J, Lou LG, Huang XY, Lou SJ, Pei G, Chen YZ 1998 Nongenomic mechanisms of glucocorticoid inhibition of nicotine-induced calcium influx in PC12 cells: involvement of protein kinase C. Endocrinology 139:5103-5108
28. Long F, Wang YX, Liu L, Zhou J, Cui RY, Jiang CL 2005 Rapid nongenomic inhibitory effects of glucocorticoids on phagocytosis and superoxide anion production by macrophages. Steroids 70:55-61
29. Liu L, Wang YX, Zhou J, Long F, Sun HW, Liu Y, Chen YZ, Jiang CL 2005 Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflamm Res 54:37-41
30. Koukouritaki SB, Gravanis A, Stournaras C 1999 Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol Med 5:731-742
31. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
32. Bagowski CP, Myers JW, Ferrell Jr JE 2001 The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J Biol Chem 276:37708-37714
33. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M 2005 Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 102:19204-19207
34. Song IH, Buttgereit F 2006 Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 246:142-146